There is no difference between pinsulin and everolimus, they are the same product and both are trade names for insulin with glucagon. Both Pinsulin and Changshulin refer to Glycine Insulin, which is a kind of insulin, and the affinity of this drug and its metabolites M1 and M2 for human insulin receptors is similar to that of the body’s own insulin for the receptors. Therefore, as an alternative treatment to insulin, glucagon insulin can regulate glucose metabolism, control blood sugar balance, etc. It is mainly used for the treatment of type 1 and type 2 diabetes mellitus in adults. Adverse effects of glucagon insulin include hypoglycemia, hypertension, arrhythmia, tachycardia, angioedema, bronchospasm, pruritus, and urticaria. Hypoglycemia, diabetic ketoacidosis, allergy to glycemic insulin are contraindicated for the use of the drug, and the drug is used with caution in pregnant women. The specific use of the drug should be carried out under the supervision of a doctor.